Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies

Abstract

BackgroundThe Patient Health Questionnaire (PHQ) is the most commonly used measure to screen for depression in primary care but there is still lack of clarity about its accuracy and optimal scoring method.AimsTo determine via meta-analysis the diagnostic accuracy of the PHQ-9-linear, PHQ-9-algorithm and PHQ-2 questions to detect major depressive disorder (MDD) among adults.MethodWe systematically searched major electronic databases from inception until June 2015. Articles were included that reported the accuracy of PHQ-9 or PHQ-2 questions for diagnosing MDD in primary care defined according to standard classification systems. We carried out a meta-analysis, meta-regression, moderator and sensitivity analysis.ResultsOverall, 26 publications reporting on 40 individual studies were included representing 26 902 people (median 502, s.d.=693.7) including 14 760 unique adults of whom 14.3% had MDD. The methodological quality of the included articles was acceptable. The meta-analytic area under the receiver operating characteristic curve of the PHQ-9-linear and the PHQ-2 was significantly higher than the PHQ-9-algorithm, a difference that was maintained in head-to-head meta-analysis of studies. Our best estimates of sensitivity and specificity were 81.3% (95% CI 71.6–89.3) and 85.3% (95% CI 81.0–89.1), 56.8% (95% CI 41.2–71.8) and 93.3% (95% CI 87.5–97.3) and 89.3% (95% CI 81.5–95.1) and 75.9% (95% CI 70.1–81.3) for the PHQ-9-linear, PHQ-9-algorithm and PHQ-2 respectively. For case finding (ruling in a diagnosis), none of the methods were suitable but for screening (ruling out non-cases), all methods were encouraging with good clinical utility, although the cut-off threshold must be carefully chosen.ConclusionsThe PHQ can be used as an initial first step assessment in primary care and the PHQ-2 is adequate for this purpose with good acceptability. However, neither the PHQ-2 nor the PHQ-9 can be used to confirm a clinical diagnosis (case finding).Declaration of interestNone.Copyright and usage© The Royal College of Psychiatrists 2016. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) licence.

Diagnostic Accuracy of Screening and Treatment of Post–Acute Coronary Syndrome Depression: A Systematic Review

“…70,71 Estimates of sensitivity, specificity, and NPV for the BDI-II from studies included in this review are in line with those found in other studies, 72 with PPV estimates from included studies in this review near the lower range but generally consistent with PPV estimates produced in other medical samples. The GDS, HADS, and PHQ did not have uniform versions (i.e., they differed in either items assessed or cutpoint used) employed in more than two studies in the present review, limiting comparability with other research, though in general the reported metrics from presently included studies appear broadly consistent with those reported from studies that have examined these measures in other non-post-ACS populations.…”

Positive association between Toxoplasma gondii IgG serointensity and current dysphoria/hopelessness scores in the Old Order Amish: a preliminary study

“…Our PHQ-9 and PHQ-2 questionnaires were modified after feedback from members of the Amish community, and thus, the scores and thresholds on those questionnaires cannot be directly used to estimate diagnosis in the absence of thorough validation. Under any circumstances, meta-analyses have reported that both PHQ-9 and PHQ-2 scales cannot be used to clinically diagnose depression but they are useful for screening and referral for further clinical evaluation [37, 38]. …”

“…The questionnaires also asked if the participant had experienced either of these feelings in the past. Studies have reported that PHQ-9 has a sensitivity ranging from 80% to 81.3% and specificity ranging from 85.3% to 92% [37, 38] and the PHQ-2 sensitivity ranges from 83% to 89.3% and its specificity ranges from 75.9% to 92% [36, 38]. …”

Relationship between physicians' perceived stigma toward depression and physician referral to psycho‐oncology services on an oncology/hematology ward

“…The PHQ‐9 questionnaire is commonly used to screen patients for depression . It is composed of 9 items that are designed to check the symptoms of major depressive disorder as defined in the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV) .…”

“…In a systematic review of the psychological problems of cancer patients, the National Comprehensive Cancer Network recommended routine screening for distress, including depression . Distress among these patients is commonly assessed using the distress thermometer or the Patient Health Questionnaire‐9 (PHQ‐9) . Actually, the implementation of referral systems incorporating a screening tool produces several positive outcomes, such as reduced depression, increased doctor‐to‐patient communication, and the facilitation of referrals to a psycho‐oncology service …”